# Early Administration of Intravenous Hydration and Opioid Analgesics Is Correlated with Decreased Admission Rates during Vaso-Occlusive Episodes in Sickle Cell Disease

**Authors:** Bowon Joung, Ethan Miles, Farris Al-Manaseer, Won Jin Jeon, Darren Wijaya, Jin Hyun Moon, Philip Han, Jae Lee, Akhil Mehta, Alan Tseng, Kaylin Ngo, Huynh Cao, Esther G. Chong

PMC · DOI: 10.3390/jcm13071858 · 2024-03-23

## TL;DR

Giving IV hydration and painkillers quickly in sickle cell disease patients reduces hospital admissions during pain crises.

## Contribution

Shows that early IV analgesics and hydration significantly lower admission rates during vaso-occlusive episodes.

## Key findings

- 18.2% admission rate when both IV analgesics and hydration were given within 60 minutes.
- 25.6% admission rate with IV hydration alone within 60 minutes.
- Timely treatment correlates with reduced hospital admissions in sickle cell disease patients.

## Abstract

Background: Painful vaso-occlusive episodes (VOEs) are the hallmark of sickle cell disease (SCD) and account for frequent visits to the emergency department (ED) or urgent care (UC). Currently, the early administration of analgesics is recommended as initial management; however, there is a need for further understanding of the effect of prompt analgesics and hydration during VOEs. The objective of this study is to analyze the factors associated with the rate of hospital admission in the setting of time to intravenous (IV) analgesics and hydration. Method: This retrospective single-institution study reviewed adult and pediatric patients with SCD who presented with VOEs from January 2018 to August 2023. Results: Of 303 patient encounters, the rates of admission for the overall group, the subgroup which received IV hydration within 60 min of arrival, and the subgroup which received both IV analgesics and hydration within 60 min were 51.8%, 25.6% (RR = 0.46), and 18.2% (RR = 0.33), respectively. Further, factors such as gender and the use of hydroxyurea were found to be significantly associated with the rate of admission. Conclusions: This signifies the importance of standardizing the management of VOEs through the timely administration of IV analgesics and hydration in both adult and pediatric ED/UC.

## Linked entities

- **Chemicals:** hydroxyurea (PubChem CID 3657)
- **Diseases:** sickle cell disease (MONDO:0011382)

## Full-text entities

- **Diseases:** VOEs (MESH:D001157), Painful vaso-occlusive episodes (MESH:D010146), SCD (MESH:D000755)
- **Chemicals:** hydroxyurea (MESH:D006918)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC11012470/full.md

---
Source: https://tomesphere.com/paper/PMC11012470